Dr John Campbell
Dr John Campbell
@campbellteaching·3.3M subscribers·3.1K videos

New viral vector vaccine

Posted

May 30, 2026

Views

75,538

Likes

6,661

Comments

1,307

Engagement

10.55%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

For Ebola. New vaccines for Bundibugyo ebolavirus

ChAdOx1 Bundibugyo vaccine (Oxford / Serum Institute)

Uses the chimpanzee adenovirus (ChAdOx1) platform

Similar technology was used in the Oxford AZ COVID-19 vaccine

Potentially be ready for early efficacy assessment in 2–3 months

How the ChAdOx system works

Genes for the antigen are inserted into a viral vector

Injection(im)

Biodistribution

Cell entry

Delivers DNA instructions into the cell

Antigen production

Cell manufactures the viral protein:

Both cause human cells to manufacture a viral antigen

COVID vaccine → spike protein

Ebola vaccine → Ebola glycoprotein

For the SARS-CoV-2, spike protein, immunologically important antigen, is believed to be associated with cells surfaces rather than freely circulating.

Guests & Subjects Covered

For Ebola NewChAdOx BundibugyoSerum Institute UsesOxford AZ COVID-Injectionim Biodistribution CellDelivers DNA

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

New viral vector vaccine · Dr John Campbell · Sentinel